{"name":"Elgan Pharma Ltd.","slug":"elgan-pharma-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"ELGN-2112","genericName":"ELGN-2112","slug":"elgn-2112","indication":"Type 2 diabetes","status":"phase_3"}]}],"pipeline":[{"name":"ELGN-2112","genericName":"ELGN-2112","slug":"elgn-2112","phase":"phase_3","mechanism":"ELGN-2112 is a small molecule that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxQRmRkWmRONDdMRnNuNl9Ed0hwTmFxSm5LdlNQWmNnc2I1b3c2VV8yWUZJN1AxRmhodHhGaTRKRjhJWW1nMENsdEd2VHE3Q182YUkwWnR4OUUxQkM1aE9TYzBMSHNvZTJpVFRqZW0yOWNQbU1jRkIzcUNVMGd5UlVJYVh2MGtYZ2djWXdudWo5MzJfbEhFZW1SU0dpMHhXU1M2a0E?oc=5","date":"2026-02-15","type":"pipeline","source":"Telegraph and Argus","summary":"Bradford one of UK's top recruiting sites for global clinical studies - Telegraph and Argus","headline":"Bradford one of UK's top recruiting sites for global clinical studies","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-01-03","type":"pipeline","source":"globenewswire.com","summary":"Dry Eye Products Market Opportunities and Strategies to - globenewswire.com","headline":"Dry Eye Products Market Opportunities and Strategies to","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":2,"visitCount":7,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}